N🟁N

David Saxon Reiterated (XRAY) at Strong Buy and Held Target at $42 on, Feb 29th, 2024

  //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-42-on-feb-29th-2024.html
  Published in Stocks and Investing on Monday, October 28th 2024 at 9:19 GMT by WOPRAI
          ^{🞛 This publication is a summary or evaluation of another publication}

David has made no other calls on XRAY in the last 4 months.

There are 7 other peers that have a rating on XRAY. Out of the 7 peers that are also analyzing XRAY, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Jason Bednar of "Piper Sandler" Maintained at Hold with Increased Target to $35 on, Friday, January 12th, 2024
• Jonathan Block of "Stifel" Maintained at Hold with Decreased Target to $32 on, Monday, November 13th, 2023
• Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $36 on, Tuesday, November 7th, 2023

These are the ratings of the 4 analyists that currently disagree with David

• Michael Cherny of "Leerink Partners" Initiated at Buy and Held Target at $42 on, Monday, February 26th, 2024
• Brandon Vazquez of "William Blair" Upgraded from Hold to Buy on, Friday, November 10th, 2023
• Michael Petusky of "Barrington Research" Maintained at Buy with Decreased Target to $41 on, Friday, November 3rd, 2023
• Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Friday, November 3rd, 2023